Today’s top gainers include the company GlaxoSmithKline plc (NYSE:GSK) which is in the industry Drug Manufacturers – Major, gaining -0.48% today. In the last week its performance is -0.22%, and 7.66% for the past quarter. Currently, GlaxoSmithKline plc, GSK has a target price of 48.67, so today’s gain of -0.48% is a significant step towards its target price. The GAP today is therefore -1.26%.
GlaxoSmithKline plc (NYSE:GSK), has a market cap of 109493.46, and is based in United Kingdom. Insider ownership is at 0.20%, and institutional ownership is 8.80%.
At the current price of 44.86, it has a dividend yield of 4.88%, and its target price is 48.67. This is with a profit margin of 0.10%, and total debt/equity of 34.11. GlaxoSmithKline plc (NYSE:GSK) has a P/E of 3220, as well as a forward P/E of 17.08.
With a current EPS of 0.01, and a forecasted EPS growth for next year at 15.89%,GlaxoSmithKline plc (NYSE:GSK) has had a EPS growth for the past five years at 40.20%. For the next five years EPS growth is projected to be 10.00%.
Performance for the year is 9.66%. Since its IPO date on 7/9/1986, the total performance to date is 16.79%.
Volume today for GlaxoSmithKline plc (NYSE:GSK), is 1884620, while its average volume is 3452.13. Whilst the total gain today was -0.48%, it did have a day high of -1.57%.
Volatility for this week has been at 1.00%, and 0.98% for the month. The 52-week low for GlaxoSmithKline plc, GSK has been 27.73%, while the 52-week-high has reached -1.57%.
Looking at its return of investments, which is 41.40%, and its return on assets is 0.10%. GlaxoSmithKline plc (NYSE:GSK) has an operating margin of 5.30%. With a sales growth of 10.90% quarter over quarter. Bearing in mind that GlaxoSmithKline plc, GSK is in the sector Healthcare, its long-term debt/equity is 26.3, and has a current ratio of 0.9 and 0.6 for quick ratio.
So what is the value of GlaxoSmithKline plc? Well its PEG is 322, and the P/S is 3.3, along with a P/B of 145.42. Meanwhile it has a p/cash of 17.8.